Annual ROE
23.55%
+4.79%+25.53%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual return on equity is currently 23.55%, with the most recent change of +4.79% (+25.53%) on 31 December 2023. During the last 3 years, it has risen by +23.23% (+7259.38%). AMPH annual ROE is now at all-time high.AMPH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
23.56%
-2.38%-9.18%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly return on equity is currently 23.56%, with the most recent change of -2.38% (-9.18%) on 30 September 2024. Over the past year, it has dropped by -0.89% (-3.64%). AMPH quarterly ROE is now -9.18% below its all-time high of 25.94%, reached on 30 June 2024.AMPH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +25.5% | -3.6% |
3 y3 years | +7259.4% | +193.4% |
5 y5 years | +1536.0% | +77.4% |
AMPH ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +7259.4% | -9.2% | +193.4% |
5 y | 5 years | at high | +1536.0% | -9.2% | +7262.5% |
alltime | all time | at high | +687.3% | -9.2% | +538.7% |
Amphastar Pharmaceuticals ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 23.56%(-9.2%) |
June 2024 | - | 25.94%(+2.1%) |
Mar 2024 | - | 25.40%(+7.1%) |
Dec 2023 | 23.55%(+25.5%) | 23.71%(-3.0%) |
Sept 2023 | - | 24.45%(+28.1%) |
June 2023 | - | 19.08%(+4.9%) |
Mar 2023 | - | 18.19%(-2.2%) |
Dec 2022 | 18.76%(+35.1%) | 18.59%(+13.6%) |
Sept 2022 | - | 16.37%(-16.4%) |
June 2022 | - | 19.58%(+9.4%) |
Mar 2022 | - | 17.89%(+29.2%) |
Dec 2021 | 13.89%(+4240.6%) | 13.85%(+72.5%) |
Sept 2021 | - | 8.03%(+247.6%) |
June 2021 | - | 2.31%(+312.5%) |
Mar 2021 | - | 0.56%(+75.0%) |
Dec 2020 | 0.32%(-97.4%) | 0.32%(-79.1%) |
Sept 2020 | - | 1.53%(+62.8%) |
June 2020 | - | 0.94%(-92.4%) |
Mar 2020 | - | 12.40%(+3.2%) |
Dec 2019 | 12.36% | 12.01%(-9.6%) |
Sept 2019 | - | 13.28%(-7.7%) |
June 2019 | - | 14.39%(+2080.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | 0.66%(-138.8%) |
Dec 2018 | -1.64%(-249.1%) | -1.70%(-17.5%) |
Sept 2018 | - | -2.06%(-25.6%) |
June 2018 | - | -2.77%(+113.1%) |
Mar 2018 | - | -1.30%(-215.0%) |
Dec 2017 | 1.10%(-65.0%) | 1.13%(-853.3%) |
Sept 2017 | - | -0.15%(-114.7%) |
June 2017 | - | 1.02%(-60.6%) |
Mar 2017 | - | 2.59%(-17.8%) |
Dec 2016 | 3.14%(-423.7%) | 3.15%(-54.2%) |
Sept 2016 | - | 6.88%(+45.1%) |
June 2016 | - | 4.74%(+3546.2%) |
Mar 2016 | - | 0.13%(-113.3%) |
Dec 2015 | -0.97%(-75.8%) | -0.98%(-78.4%) |
Sept 2015 | - | -4.54%(-15.5%) |
June 2015 | - | -5.37%(+52.6%) |
Mar 2015 | - | -3.52%(-10.9%) |
Dec 2014 | -4.01%(-182.0%) | -3.95%(+67.4%) |
Sept 2014 | - | -2.36%(+448.8%) |
June 2014 | - | -0.43%(-113.7%) |
Mar 2014 | - | 3.13%(-33.7%) |
Dec 2013 | 4.89%(-36.9%) | 4.72% |
Dec 2012 | 7.75% | - |
FAQ
- What is Amphastar Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual ROE year-on-year change?
- What is Amphastar Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly ROE year-on-year change?
What is Amphastar Pharmaceuticals annual return on equity?
The current annual ROE of AMPH is 23.55%
What is the all time high annual ROE for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual return on equity is 23.55%
What is Amphastar Pharmaceuticals annual ROE year-on-year change?
Over the past year, AMPH annual return on equity has changed by +4.79% (+25.53%)
What is Amphastar Pharmaceuticals quarterly return on equity?
The current quarterly ROE of AMPH is 23.56%
What is the all time high quarterly ROE for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly return on equity is 25.94%
What is Amphastar Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, AMPH quarterly return on equity has changed by -0.89% (-3.64%)